Medical Cannabis for MS UK — Spasticity, Pain & Sleep

Multiple sclerosis affects approximately 130,000 people in the UK, making it one of the most common neurological conditions. Medical cannabis has received its strongest UK clinical backing for MS-related symptoms, particularly muscle spasticity. Nabiximols (Sativex), an oral spray containing equal parts THC and CBD, is the only cannabis medicine licensed by the MHRA specifically for MS spasticity. It is available on the NHS in some parts of England, Scotland and Wales for patients who have not responded to other spasticity treatments. Beyond Sativex, UK private clinics prescribe a range of cannabis products for MS patients. Flower products and oils are used for pain, sleep disruption and anxiety associated with MS. Indica-dominant strains with myrcene are commonly recommended for muscle spasms. MS UK and other patient organisations have advocated for improved NHS access to cannabis medicines. Use LeafMe to find MS-specialist clinics and compare product availability.